# Quest Diagnostics Incorporated (DGX): MoatMap facts

As of 29 Oct 2026. Research data, not investment advice.

As of 29 Oct 2026, MoatMap's StockRank for Quest Diagnostics Incorporated (DGX) is 83/100, ranked against 24,000+ stocks in 35 markets (Quality 66, Value 48, Momentum 67, each scored against its sector).

- StockRank: 83/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 66, Value 48, Momentum 67: each a 0-100 percentile within Healthcare.
- Position: #4,433 overall, #492 in Healthcare.
- Listing: United States, NYQ; Healthcare / Diagnostics & Research.
- Last close: 245.62 USD on 28 Oct 2026.
- Insider filings, last 180 days: directors sold USD 11.9M.
- Buybacks, last 180 days: the company bought back USD 400.0M on 2 days.

Source: https://moatmap.ai/stock/DGX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker